Cyberonics (CYBX) Announces Epilepsy Technology Collaborations
Cyberonics, Inc. (Nasdaq: CYBX) announced two collaborations in the field of EEG-based seizure detection to build on its position as the leader in medical devices for epilepsy.
On October 1, 2009, Cyberonics entered into a License Agreement with NeuroVista Corporation, providing Cyberonics with access to a range of technology and patents in exchange for payments extending through April 2011. The NeuroVista technology will enable Cyberonics to accelerate its program for development of an implantable pulse generator for stimulating the vagus nerve in response to EEG-based detection of a seizure and includes technology related to an algorithm for seizure detection, a rechargeable battery system, wireless communication, and an implantable lead.
Create E-mail AlertRelated Categories
Corporate NewsFDA
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
